# Avarax

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/avarax

- Industry: Pharmaceuticals
- Headquarters: Australia
- Total disclosed funding: $3.5M
- Latest round: Seed (Nov 23, 2015)
- Investors on record: 1

## About

Based in Australia, Avarax is a developer of vaccine for peanut allergies.

## Funding rounds

- Seed, Nov 23, 2015, $3.5M — Brandon Capital Partners

## Investors

- Brandon Capital Partners (https://capitalatlas.ai/funds/brandon-capital-partners) — Seed